Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Type 1 Diabetes Susceptibility Through VSL#3 Probiotic-induced Alterations in the Intestinal Microbiota

NCT03423589 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT03423589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03423589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Type 1 Diabetes Susceptibility Through VSL#3 Probiotic-induced Alterations in the Intestinal Microbiota
Lead sponsor
Medical College of Wisconsin
Phase
Not applicable
Overall status
Completed
Start date
April 23, 2018
Completion date
December 31, 2018
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type1 diabetes mellitus, type1diabetes